Economic analyses and lung cancer. - Sorbonne Université
Article Dans Une Revue Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace / Fondazione clinica del lavoro, IRCCS [and] Istituto di clinica tisiologica e malattie apparato respiratorio, Università di Napoli, Secondo ateneo Année : 2001

Economic analyses and lung cancer.

A. Vergnenègre
  • Fonction : Auteur
L. Molinier
  • Fonction : Auteur

Résumé

The economic assessment of treatments or medical strategies has been the subject of an increasing number of publications. The elevated costs and relative lack of efficacy of many treatments of chronic diseases such as lung cancer are an added impetus to such analyses. In the first part of this review, we summarise the theoretical basis of economic assessment, the tools available and the limitations of these methods. In the second part, we examine their application to the treatment of lung cancer. We discuss the evaluation of the cost of these cancers to society, economic assessment of new chemotherapeutic drugs, and the place of cost-effectiveness analysis in randomized trials. In the last part, we outline the interest and future of such considerations for clinicians. These methods, which provide complementary data for clinicians when making decisions on therapeutic options, will be adopted more widely in coming years.
Fichier non déposé

Dates et versions

hal-00597292 , version 1 (31-05-2011)

Identifiants

  • HAL Id : hal-00597292 , version 1
  • PUBMED : 11770217

Citer

A. Vergnenègre, L. Molinier, C. Chouaïd. Economic analyses and lung cancer.. Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace / Fondazione clinica del lavoro, IRCCS [and] Istituto di clinica tisiologica e malattie apparato respiratorio, Università di Napoli, Secondo ateneo, 2001, 56 (4), pp.336-43. ⟨hal-00597292⟩
17 Consultations
0 Téléchargements

Altmetric

Partager

More